Health data: what the CNIL's new MR-001 and MR-003 methodologies require
The CNIL is overhauling its reference methodologies MR-001 and MR-003, which govern health data research. This is a paradigm shift: moving from administrative compliance to verifiable operational security on the ground. For healthcare, biotech, and insurance stakeholders, this means mandatory automated data purges, multi-factor authentication to be deployed before January 1, 2027, then 2028, restructured frameworks with two binding appendices, and European alignment. The changes apply immediately to new research, with a one-year transition period for ongoing processing.

The CNIL has overhauled its reference methodologies MR-001 and MR-003, which govern health data research. For healthcare, biotech, and insurance stakeholders, this is not merely a technical adjustment but a paradigm shift: the transition from administrative compliance to verifiable operational security on the ground.
MR-001 and MR-003: From Administrative Compliance to Operational Security
To understand the scope of the overhaul published by the National Commission for Information Technology and Civil Liberties (CNIL), it is necessary to place the reference methodologies MR-001 and MR-003 in their historical context. Established following the major post-GDPR framework reform in 2018, these key standards initially aimed to simplify procedures for researchers. Instead of requesting specific authorization for each project, research sponsors could begin their work immediately, provided they signed a commitment to comply with these pre-established frameworks. The distinction was then binary: MR-001 governed research involving human subjects, in line with the Jardé Law, while MR-003 regulated so-called non-interventional studies, based on the reuse of already collected data.
However, the landscape of medical research and e-health has profoundly evolved over the past eight years. The massive development of decentralized clinical trials, the rise of telemedicine platforms, and the increasing integration of artificial intelligence have rendered the old formalism obsolete. The boundaries between care and research have blurred, and the volumes of information stored by biotechnology laboratories, hospitals, and insurance companies have reached unprecedented levels. In response to this transformation, the supervisory authority is shifting its focus from a purely administrative compliance logic to a requirement for verifiable operational and technological security on the ground.
A Reform Driven by the Internationalization of Research
The publication of the new texts formalizes a major adaptation to the realities of a globalized health market. The reference methodologies now explicitly integrate the specificities of international multicenter studies and the complete digitization of patient consents or non-oppositions. This new framework aligns directly with the latest guidelines from the European Data Protection Board. This European convergence provides French entities, as well as international consortia operating within the national territory, with essential legal certainty to conduct cross-border research projects without regulatory distortion.
A major development also lies in the expanded scope of these texts. Eligibility criteria have been relaxed to encompass new categories of data processing, thereby sparing innovative organizations from the lengthy and uncertain prior authorization process. In return for this increased accessibility, the CNIL is drastically raising the level of security and governance requirements imposed on data controllers.
Automated Data Purges: The New Obligation for Data Lifecycle Management
The core of this reform addresses the weakest link in the digital health value chain: the indefinite retention of files. The CNIL now imposes absolute strictness regarding the end-of-life of research databases. Biotechnology and insurance companies can no longer passively store historical data under the pretext of potential future analyses. Each project must, from its design phase, integrate automated purging scripts and mechanisms, ensuring the definitive deletion or irreversible anonymization of records as soon as the authorized retention period is reached.
This institutional resolve stems from a clear-eyed analysis of the cybersecurity crises that have shaken the French healthcare system. Massive data breaches suffered by third-party payment operators and technical service providers have highlighted a critical reality: the main risk factor for compromise and penalties lies in the retention of outdated data. These archive servers, often less monitored by technical teams, are priority targets for cybercriminal networks. By making automatic data purging mandatory, the supervisory authority is drastically reducing the attack surface of institutions.
Multi-factor Authentication: The Compliance Timeline
To counter the sophistication of cyberattacks, raising logical barriers is becoming a binding standard. The new reference methodologies establish the obligation to deploy robust multi-factor authentication for all users accessing research data. This measure aims to neutralize data theft through simple credential compromise, a technique frequently used in recent large-scale intrusions.
The implementation timeline dictates a precise path for IT departments:
- research services and platforms directly accessible via the internet must integrate this dual level of verification before January 1, 2027
- other application infrastructures and internal networks of establishments have until January 1, 2028
This gradual but mandatory deployment forces organizations to plan their technical investments today.The tripartite structure of the new MR-001 and MR-003 guidelines
For legal and compliance professionals, the distinction between the old and new regimes revolves around three precise structural criteria.
Two binding and enforceable annexes
The very structure of the legal texts has been rethought. Methodologies MR-001 and MR-003 abandon the single document format to adopt a tripartite architecture. They are now accompanied by two binding and enforceable annexes. The first exhaustively lists the required technical and organizational security measures. The second strictly governs the quality control operations essential for validating the integrity and accuracy of the data processed.
Compliance grids and self-assessment questionnaires
The nature of assessment tools is evolving towards greater pragmatism. To break away from a sometimes complex doctrinal approach, the CNIL provides interactive compliance grids and self-assessment questionnaires. These practical tools allow project teams to verify the compliance of their processing operations point by point without risk of misinterpretation.
Official publication in French and English
Linguistic accessibility is enhanced to meet market demands. The guidelines benefit from simultaneous official publication in French and English. This approach facilitates the adoption of the rules by foreign sponsors and streamlines the implementation of international clinical trials on French soil.
Compliance roadmap for healthcare, biotech, and insurance
The entry into force of these new requirements necessitates differentiated action plans based on project maturity. For all research initiated from today, the application of automated purging rules and enhanced security is immediately required. However, for data processing already active before the publication of this reform, operators have a full year transition period to adapt their systems and formalize their compliance.
This transition period involves in-depth auditing and restructuring. Promoters must review their entire subcontracting chain, particularly contracts linking laboratories to contract research organizations, medical software publishers, and certified health data hosts. Internally, data protection officers and information system security managers must update privacy impact assessments and processing activity records. Whether for biotech startups based in Paris or mutual insurance companies located in regional city centers, anticipating these rules is the best protection against reputational risk and financial penalties.
FAQ - CNIL Reference Methodologies MR-001 and MR-003
What are Reference Methodologies MR-001 and MR-003?
These are CNIL frameworks that govern health data research. Rather than requesting authorization for each project, promoters can begin their work by signing a commitment to comply with these pre-established guidelines.
What is the difference between MR-001 and MR-003?
MR-001 governs research involving human subjects, in line with the Jardé Law. MR-003 regulates non-interventional studies, based on the reuse of already collected data.
What changes with the CNIL reform?
The logic shifts from administrative compliance to verifiable operational security. Eligibility criteria are relaxed, but security and governance requirements are significantly enhanced: automated purges, multi-factor authentication, enforceable annexes, and alignment with the European Data Protection Board.
What is an automated purge of health data?
It's an IT mechanism integrated from the project's design phase that ensures the definitive deletion or irreversible anonymization of records as soon as the authorized retention period is reached. The goal is to reduce the attack surface by eliminating outdated data, which is a primary target for cybercriminals.
What are the deadlines for multi-factor authentication?
Internet-accessible search services and platforms must integrate it by January 1, 2027. Other internal application and network infrastructures have until January 1, 2028.
What is the timeframe for compliance?
The new rules apply immediately to searches initiated after the reform's publication. Existing processing activities benefit from a one-year transition period to adapt their systems and formalize their compliance.
